Melbourne Biomedical Precinct (Parkville)
Access world-leading biomedical capability, technologies and infrastructure in Melbourne's Biomedical Precinct
Melbourne's Biomedical Precinct is Australia’s, and one of the world’s, leading biomedical centres. The precinct delivers outstanding healthcare, education and world-class research. It is home to some of the biggest global names in the biomedical sector and is an excellent environment for research based commercial activity.
Melbourne Biomedical Precinct’s cutting edge research and discoveries have resulted in major advances in patient care, disease treatment breakthroughs and development of devices, technologies and medicines that have saved and improved lives in Victoria, Australia and around the world.
It is a place where ideas flourish and where researchers and institutions are both locally and globally connected. It is a an ideal location for knowledge transfer and innovation.
The Melbourne Biomedical Precinct's research and development infrastructure and vibrant culture make it a highly sought-after destination by global companies and research institutions. We can help you find the right location.
NEWS: A new infectious disease centre to boost Melbourne's Biomedical precinct
Biomedical leaders choose to operate in the precinct.
Successfully leveraging Melbourne's Biomedical Precinct is Australia’s largest pharmaceutical company (CSL), along with some of the biggest global names and niche operators in biomedical research.
- CSL Limited
- BioGrid Australia
- Melbourne Bioinformatics
- Melbourne Brain Centre
- Australian Genome Research Facility
- Bio21 Molecular Science and Biotechnology Institute
- National Ageing Research Institute
We can connect you with the world-class institutions and research infrastructure available in this precinct.
Invest Victoria can assist you establish valuable connections, research partnerships, or leverage existing state of the art infrastructure.
We can also help you explore opportunities to build and create your own independent infrastructure and research projects within this highly collegiate environment.
The Biomedical Precinct offers access to a high concentration of world-class institutions and research infrastructure, including:
Hospitals
- The Royal Melbourne Hospital
- The Royal Children’s Hospital
- The Royal Women’s Hospital
- Frances Perry House
Universities
- University of Melbourne
- RMIT
- Monash Institute of Pharmaceutical Science, Monash University
Medical Research Institutes
- Walter and Eliza Hall Institute
- Victorian Comprehensive Cancer Centre
- The Florey Institute of Neuroscience and Mental health
- Murdoch Children’s Research Institute
- Peter Doherty Institute for Infection and Immunity
- Peter MacCallum Cancer Centre
- CSIRO
The Melbourne Biomedical Precinct is renowned for its cutting-edge research discoveries and improving outcomes.
It has key capabilities in areas including infectious diseases and immunology, neurosciences including mental health, cancer, child health and healthy ageing, working with some of the most respected global names in biomedical research.
The Melbourne Biomedical Precinct employs 49,000 people and educates over 7,000 biomedical, health and medical students each year and attracts more annual competitive biomedical research funding than any other area in Australia.
Case studies: Life science
Melbourne Biomedical Precinct is located just outside Melbourne’s CBD
Melbourne precinct spans from Parkville’s northern boundary, extending through Parkville and across Carlton to East Melbourne.
Beyond this immediate area, Victoria’s biotechnology sector is rich, complex and includes other important precincts such as Clayton Innovation Cluster and the Alfred Medical Research and Education Precinct.
We can help you with your next market entry project
If you are considering investing in Melbourne, we can help you scope the market opportunity in Melbourne/Australia and assist you with your business case development.
Working with us will allow you to be fully informed and limit the number of surprises associated with your new investment. Our staff are experienced and well connected and can introduce you to potential partners to help make your investment a success.
Contact us
|
|  |
|---|---|---|
| UK and Europe enquiries contact Tim Dillon Agent General, UK Email Tim | US enquiries contact Nigel Warren Commissioner, the Americas Email Nigel | SE Asia enquires contact Georgina McCann Acting Head of Post, South East Asia Email Georgina |
Or go to our All Offices page to find your nearest Invest Victorian representative.
